DEPAKENE Side Effects

7022888-0 | Convulsion, Product Counterfeit
on Sep 23, 2010 Female patient from FRANCE , 19 years of age, was diagnosed with partial seizures and was treated with Depakene (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, product counterfeit. Depakene dosage: Extended Release. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ).

7020726-3 | Dystonia, Hypertension
Patient was taking Depakene (View Usage). Patient had the following side effects: dystonia (What is dystonia?), hypertension on Sep 20, 2010 from POLAND Additional patient health information: Female patient , 31 years of age, was diagnosed with schizophrenia, paranoid type and. Depakene dosage: Daily. During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ), RISPERIDINE (View Risperidine Review and Risperidine Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ). Patient was hospitalized.

7013927-1 | Epilepsy, Premature Labour
Adverse event was reported on Sep 24, 2010 by a Female patient taking Depakene (View Usage) (Dosage: 500 Mg Form Strength) was diagnosed with epilepsy (What is epilepsy?), hiv infection (What is hiv infection?) and. Location: FRANCE , 43 years of age, After Depakene was administered, patient had the following side effects: epilepsy (What is epilepsy?), premature labour. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), PREZISTA (View Prezista Review and Prezista Label ), TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

7013812-5 | Enterocolitis Haemorrhagic, International Normalised Ratio Increased, Petechiae
on Sep 16, 2010 Male patient from SWITZERLAND , 72 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), cardiac flutter and was treated with Depakene (View Usage). Patient experienced the following unwanted or unexpected effects: enterocolitis haemorrhagic, international normalised ratio increased, petechiae. Depakene dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), SINTROM (View Sintrom Review and Sintrom Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), NEXIUM (View Nexium Review and Nexium Label ), IMIPENEM AND CILASTATIN SODIUM (View Imipenem And Cilastatin Sodium Review and Imipenem And Cilastatin Sodium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).


7013326-2 | Hyperkalaemia, Inappropriate Antidiuretic Hormone Secretion, Pneumonia
on Sep 21, 2010 Male patient from FRANCE , 32 years of age, was diagnosed with hypertrophic cardiomyopathy and was treated with Depakene (View Usage). Patient had the following side effects: hyperkalaemia, inappropriate antidiuretic hormone secretion, pneumonia (What is pneumonia?). Depakene dosage: . During the same period patient was treated with ISOPTIN SR (View Isoptin Sr Review and Isoptin Sr Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MEPRONIZINE (View Mepronizine Review and Mepronizine Label ), MODECATE (View Modecate Review and Modecate Label ), VICTAN (View Victan Review and Victan Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ). Patient was hospitalized.

7010850-3 | Epilepsy, Premature Labour
Patient was taking Depakene (View Usage). After Depakene was administered, patient had the following side effects: epilepsy (What is epilepsy?), premature labour on Sep 13, 2010 from FRANCE Additional patient health information: Female patient , 43 years of age, was diagnosed with epilepsy (What is epilepsy?), hiv infection (What is hiv infection?) and. Depakene dosage: 500 Mg Form Strength. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), CLOZEPAM RIVOTRIL (NON ABBOTT) (View Clozepam Rivotril (non-abbott) Review and Clozepam Rivotril (non-abbott) Label ), DARUNAVIR (PREZISTA) (NON ABBOTT) (View Darunavir (prezista) (non-abbott) Review and Darunavir (prezista) (non-abbott) Label ), TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

6985758-X | Blood Creatinine Increased, Renal Failure, Tubulointerstitial Nephritis
Adverse event was reported on Sep 07, 2010 by a Male patient taking Depakene (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: FRANCE , 77 years of age, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, renal failure, tubulointerstitial nephritis. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), DIAMICRON (View Diamicron Review and Diamicron Label ). Patient was hospitalized.

6976904-2 | Anuria, Hyponatraemia, Loss Of Consciousness, Vomiting
on Sep 10, 2010 Male patient from FRANCE , 34 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Depakene (View Usage). Patient had the following side effects: anuria, hyponatraemia, loss of consciousness, vomiting. Depakene dosage: . During the same period patient was treated with URBANYL (View Urbanyl Review and Urbanyl Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), FORLAX (View Forlax Review and Forlax Label ). Patient was hospitalized.

6973129-1 | Dystonia, Hypertension
on Sep 01, 2010 Female patient from POLAND , 31 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Depakene (View Usage). After Depakene was administered, patient had the following side effects: dystonia (What is dystonia?), hypertension. Depakene dosage: Daily. During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ). Patient was hospitalized.

6971928-3 | Fall, Joint Injury, Parkinsonism, Somnolence
Patient was taking Depakene (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), joint injury, parkinsonism, somnolence on Aug 30, 2010 from FRANCE Additional patient health information: Female patient , 80 years of age, was diagnosed with abnormal behaviour and. Depakene dosage: 500mg Gastro-resistant Tablet, Twice/day. During the same period patient was treated with SERESTA (View Seresta Review and Seresta Label ), NORSET (View Norset Review and Norset Label ), DIFFU K (View Diffu K Review and Diffu K Label ), EXELON (View Exelon Review and Exelon Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ). Patient was hospitalized.

6970424-7 | Blood Creatinine Increased, Renal Failure, Tubulointerstitial Nephritis
Adverse event was reported on Sep 03, 2010 by a Male patient taking Depakene (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: FRANCE , 77 years of age, Patient had the following side effects: blood creatinine increased, renal failure, tubulointerstitial nephritis. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ZYLORIC ^GLAXO WELLCOME^ (View Zyloric ^glaxo Wellcome^ Review and Zyloric ^glaxo Wellcome^ Label ), DIAMICRON (View Diamicron Review and Diamicron Label ). Patient was hospitalized.

6966423-1 | Syncope
on Sep 05, 2010 Female patient from BRAZIL , weighting 110.2 lb, was diagnosed with syncope, prophylaxis and was treated with Depakene (View Usage). After Depakene was administered, patient had the following side effects: syncope. Depakene dosage: .

6963653-X | Conjunctivitis, Oedema Mucosal, Rash Macular, Stevens-johnson Syndrome
on Aug 25, 2010 Male patient from POLAND , 28 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Depakene (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctivitis, oedema mucosal, rash macular, stevens-johnson syndrome. Depakene dosage: . During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ).

6962531-X | Syncope
Patient was taking Depakene (View Usage). Patient had the following side effects: syncope on Aug 24, 2010 from BRAZIL Additional patient health information: Female patient , weighting 110.2 lb, was diagnosed with syncope and. Depakene dosage: .

6941457-1 | Bradyphrenia
Adverse event was reported on Aug 19, 2010 by a Female patient taking Depakene (View Usage) (Dosage: Daily Dose: 3 Units) was diagnosed with schizophrenia and. Location: ITALY , 44 years of age, After Depakene was administered, patient had the following side effects: bradyphrenia. During the same period patient was treated with DELORAZEPAM (View Delorazepam Review and Delorazepam Label ), PAROXETINE (View Paroxetine Review and Paroxetine Label ), ZIPRASIDONE HCL (View Ziprasidone Hcl Review and Ziprasidone Hcl Label ).

6941285-7 | Dystonia, Hypertension
on Aug 17, 2010 Female patient from POLAND , 31 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Depakene (View Usage). Patient experienced the following unwanted or unexpected effects: dystonia (What is dystonia?), hypertension. Depakene dosage: Daily. During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ). Patient was hospitalized.

6940327-2 | Sopor
on Aug 16, 2010 Female patient from ITALY , 33 years of age, was diagnosed with anxiety (What is anxiety?) and was treated with Depakene (View Usage). Patient had the following side effects: sopor. Depakene dosage: Once. During the same period patient was treated with DULOXETINE HYDROCHLORIDE (Once) (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ). Patient was hospitalized.

6939401-6 | Enterocolitis Haemorrhagic, International Normalised Ratio Increased, Petechiae
Patient was taking Depakene (View Usage). After Depakene was administered, patient had the following side effects: enterocolitis haemorrhagic, international normalised ratio increased, petechiae on Aug 17, 2010 from SWITZERLAND Additional patient health information: Male patient , 72 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), cardiac flutter and. Depakene dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), SINTROM (View Sintrom Review and Sintrom Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), NEXIUM (View Nexium Review and Nexium Label ), IMIPENEM AND CILASTATIN SODIUM (View Imipenem And Cilastatin Sodium Review and Imipenem And Cilastatin Sodium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).

6934625-6 | Agranulocytosis, Granulocytopenia
Adverse event was reported on Aug 11, 2010 by a Male patient taking Depakene (View Usage) (Dosage: Powder For Solution; Daily) was diagnosed with convulsion and. Location: ITALY , 75 years of age, Patient experienced the following unwanted or unexpected effects: agranulocytosis, granulocytopenia. Patient was hospitalized.

6934623-2 | Cerebrovascular Accident, Mobility Decreased, Petit Mal Epilepsy
on Aug 11, 2010 Male patient from BRAZIL , weighting 191.8 lb, was diagnosed with petit mal epilepsy, hypertension, blood cholesterol and was treated with Depakene (View Usage). Patient had the following side effects: cerebrovascular accident, mobility decreased, petit mal epilepsy. Depakene dosage: . During the same period patient was treated with CLOBAZAM (View Clobazam Review and Clobazam Label ), GARDENAL (View Gardenal Review and Gardenal Label ), ATACAND (View Atacand Review and Atacand Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized and became disabled.

6934521-4 | Suicide Attempt
on Aug 11, 2010 Female patient from SWITZERLAND , 16 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?), migraine (What is migraine?) and was treated with Depakene (View Usage). After Depakene was administered, patient had the following side effects: suicide attempt. Depakene dosage: . During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), METOPROLOL SUCCINATE (100 Milligrams Daily) (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

6933085-9 | Abdominal Pain Upper, Nausea, Pancreatic Disorder
Patient was taking Depakene (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, nausea (What is nausea?), pancreatic disorder on Aug 10, 2010 from FRANCE Additional patient health information: Female patient , 50 years of age, was diagnosed with bipolar i disorder and. Depakene dosage: . During the same period patient was treated with ZYPREXA (View Zyprexa Review and Zyprexa Label ), VALIUM (View Valium Review and Valium Label ), PLANTABEN (View Plantaben Review and Plantaben Label ), LORAMET (View Loramet Review and Loramet Label ). Patient was hospitalized.

6931148-5 | Fracture, Hypocalcaemia, Vitamin D Deficiency
Adverse event was reported on Aug 10, 2010 by a Male patient taking Depakene (View Usage) (Dosage: ) was diagnosed with partial seizures and. Location: FRANCE , 16 years of age, Patient had the following side effects: fracture (What is fracture?), hypocalcaemia, vitamin d deficiency. During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

6931108-4 | Balance Disorder, Cognitive Disorder, Dementia, Memory Impairment, Tremor
on Aug 10, 2010 Female patient from FRANCE , 88 years of age, was treated with Depakene (View Usage). After Depakene was administered, patient had the following side effects: balance disorder, cognitive disorder, dementia (What is dementia?), memory impairment, tremor. Depakene dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), CORDARONE (View Cordarone Review and Cordarone Label ), NEBIVOLOL (View Nebivolol Review and Nebivolol Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6929048-X | Blood Creatinine Increased, Renal Failure Acute, Renal Function Test Abnormal, Renal Tubular Disorder
on Aug 04, 2010 Female patient from FRANCE , 38 years of age, was diagnosed with epilepsy (What is epilepsy?), neoplasm malignant and was treated with Depakene (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, renal failure acute, renal function test abnormal, renal tubular disorder. Depakene dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), HOLOXAN (View Holoxan Review and Holoxan Label ). Patient was hospitalized.

6928540-1 | Obesity, Weight Increased
Patient was taking Depakene (View Usage). Patient had the following side effects: obesity (What is obesity?), weight increased on Aug 04, 2010 from SWITZERLAND Additional patient health information: Female patient , 37 years of age, was diagnosed with affective disorder, mental disorder, psychotic disorder (What is psychotic disorder?) and. Depakene dosage: . During the same period patient was treated with SOLIAN (View Solian Review and Solian Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), ENTUMIN (View Entumin Review and Entumin Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ).

6926484-2 | Fall, Syncope
Adverse event was reported on Aug 06, 2010 by a Male patient taking Depakene (View Usage) (Dosage: Daily Dose: 200mg) was diagnosed with epilepsy (What is epilepsy?) and. Location: ITALY , 15 years of age, After Depakene was administered, patient had the following side effects: fall (What is fall?), syncope. During the same period patient was treated with KEPPRA (Daily Dose: 1gm) (View Keppra Review and Keppra Label ).

6924034-8 | Epilepsy
on Aug 03, 2010 Male patient from SWITZERLAND , 57 years of age, was treated with Depakene (View Usage). Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?). Depakene dosage: . During the same period patient was treated with ANXIOLIT (View Anxiolit Review and Anxiolit Label ), SOMNIUM (View Somnium Review and Somnium Label ), CLOMETHIAZOLE (View Clomethiazole Review and Clomethiazole Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ). Patient was hospitalized.

6923310-2 | Abdominal Pain, Back Pain, Constipation, Convulsion, Crying, Decreased Appetite, Headache
on Aug 04, 2010 Female patient from BRAZIL , 27 years of age, was diagnosed with convulsion and was treated with Depakene (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), back pain (What is back pain?), constipation (What is constipation?), convulsion, crying, decreased appetite, headache (What is headache?). Depakene dosage: Daily Dose: 2 Units. During the same period patient was treated with GARDENAL (Twice A Day) (View Gardenal Review and Gardenal Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), AMPLICTIL (View Amplictil Review and Amplictil Label ), HIDANTAL (Daily Dose: 200mg) (View Hidantal Review and Hidantal Label ), MELLARIL (Daily Dose: 250mg) (View Mellaril Review and Mellaril Label ).

6917280-0 | Suicide Attempt
Patient was taking Depakene (View Usage). After Depakene was administered, patient had the following side effects: suicide attempt on Aug 05, 2010 from POLAND Additional patient health information: Female patient , 16 years of age, . Depakene dosage: . Patient was hospitalized.

6914820-2 | Overdose, Sopor
Adverse event was reported on Jul 30, 2010 by a Female patient taking Depakene (View Usage) (Dosage: Once) was diagnosed with anxiety (What is anxiety?) and. Location: ITALY , 33 years of age, Patient experienced the following unwanted or unexpected effects: overdose, sopor. During the same period patient was treated with DULOXETINE HYDROCHLORIDE (Once) (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ). Patient was hospitalized.

6914725-7 | Chromaturia, Confusional State, Hepatic Failure, Hepatitis, Jaundice, Prothrombin Time Shortened, Vomiting
on Jul 30, 2010 Male patient from FRANCE , 68 years of age, was diagnosed with epilepsy (What is epilepsy?), postoperative analgesia and was treated with Depakene (View Usage). Patient had the following side effects: chromaturia, confusional state, hepatic failure, hepatitis (What is hepatitis?), jaundice (What is jaundice?), prothrombin time shortened, vomiting. Depakene dosage: Extended Release. During the same period patient was treated with PERFALGAN (View Perfalgan Review and Perfalgan Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), MORPHINE (View Morphine Review and Morphine Label ), LOVENOX (View Lovenox Review and Lovenox Label ), VITAMINE B (View Vitamine B Review and Vitamine B Label ). Patient was hospitalized.

6909472-1 | Blood Creatinine Increased, Renal Failure, Tubulointerstitial Nephritis
on Jul 29, 2010 Male patient from FRANCE , 77 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Depakene (View Usage). After Depakene was administered, patient had the following side effects: blood creatinine increased, renal failure, tubulointerstitial nephritis. Depakene dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), DIAMICRON (View Diamicron Review and Diamicron Label ). Patient was hospitalized.

6907259-7 | Alanine Aminotransferase Increased, Jaundice, Liver Injury
Patient was taking Depakene (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, jaundice (What is jaundice?), liver injury on Jul 26, 2010 from FRANCE Additional patient health information: Female patient , 38 years of age, . Depakene dosage: Daily. During the same period patient was treated with OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

6907183-X | Cytolytic Hepatitis, Dermatitis Exfoliative, Eosinophilia, Pyrexia
Adverse event was reported on Jul 29, 2010 by a Male patient taking Depakene (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: FRANCE , 17 years of age, Patient had the following side effects: cytolytic hepatitis, dermatitis exfoliative, eosinophilia, pyrexia. Patient was hospitalized.

6896668-0 | Blood Creatinine Increased, Renal Failure Acute, Renal Function Test Abnormal, Renal Tubular Disorder
on Jul 23, 2010 Female patient from FRANCE , 38 years of age, was diagnosed with epilepsy (What is epilepsy?), neoplasm malignant and was treated with Depakene (View Usage). After Depakene was administered, patient had the following side effects: blood creatinine increased, renal failure acute, renal function test abnormal, renal tubular disorder. Depakene dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), HOLOXAN (View Holoxan Review and Holoxan Label ). Patient was hospitalized.

6888362-7 | Obesity, Weight Increased
on Jul 22, 2010 Female patient from SWITZERLAND , 37 years of age, was diagnosed with affective disorder, mental disorder, psychotic disorder (What is psychotic disorder?) and was treated with Depakene (View Usage). Patient experienced the following unwanted or unexpected effects: obesity (What is obesity?), weight increased. Depakene dosage: . During the same period patient was treated with SOLIAN (View Solian Review and Solian Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), ENTUMIN (View Entumin Review and Entumin Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ).

6872015-5 | Agranulocytosis, Granulocytopenia
Patient was taking Depakene (View Usage). Patient had the following side effects: agranulocytosis, granulocytopenia on Jul 16, 2010 from FRANCE Additional patient health information: Male patient , 75 years of age, was diagnosed with convulsion and. Depakene dosage: Powder For Solution; Daily. Patient was hospitalized.

6863489-4 | Agitation, Dizziness, Epilepsy, Listless, Somnolence, Speech Disorder
Adverse event was reported on Jul 12, 2010 by a Male patient taking Depakene (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?), depression (What is depression?) and. Location: BRAZIL , weighting 156.5 lb, After Depakene was administered, patient had the following side effects: agitation, dizziness (What is dizziness?), epilepsy (What is epilepsy?), listless, somnolence, speech disorder. During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), CLOPAN (View Clopan Review and Clopan Label ).

6861226-0 | Cytolytic Hepatitis, Dermatitis Exfoliative, Eosinophilia, Lymphadenopathy, Pyrexia
on Jul 12, 2010 Male patient from FRANCE , 17 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Depakene (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, dermatitis exfoliative, eosinophilia, lymphadenopathy, pyrexia. Depakene dosage: . Patient was hospitalized.

6855834-0 | Convulsion, Product Substitution Issue
on Jul 15, 2010 Male patient from UNITED STATES , weighting 121.3 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Depakene (View Usage). Patient had the following side effects: convulsion, product substitution issue. Depakene dosage: 12 Cc Po Tid. During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ), KEPPRA (View Keppra Review and Keppra Label ).

6848039-0 |
Patient was taking Depakene (View Usage). on Jul 05, 2010 from FRANCE Additional patient health information: Female patient , 20 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Depakene dosage: . During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6844760-9 | Bronchopneumonia, Renal Failure Acute, Respiratory Failure, Rhabdomyolysis
Adverse event was reported on Jul 08, 2010 by a Male patient taking Depakene (View Usage) (Dosage: ) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: FRANCE , 53 years of age, Patient experienced the following unwanted or unexpected effects: bronchopneumonia, renal failure acute, respiratory failure, rhabdomyolysis. During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), ANTIPSYCHOTICS (View Antipsychotics Review and Antipsychotics Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), FELISON (View Felison Review and Felison Label ), DELORAZEPAM (View Delorazepam Review and Delorazepam Label ). Patient was hospitalized.

6836764-7 | Motor Dysfunction, Sopor
on Jul 06, 2010 Female patient from FRANCE , 50 years of age, was diagnosed with self injurious behaviour, intentional overdose and was treated with Depakene (View Usage). Patient had the following side effects: motor dysfunction, sopor. Depakene dosage: . During the same period patient was treated with DELORAZEPAM (View Delorazepam Review and Delorazepam Label ). Patient was hospitalized.

6836487-4 | Azoospermia, Infertility Male
on Jul 07, 2010 Male patient from FRANCE , 26 years of age, was diagnosed with myoclonic epilepsy and was treated with Depakene (View Usage). After Depakene was administered, patient had the following side effects: azoospermia, infertility male. Depakene dosage: 1000 Mg Daily.

6832478-8 | Motor Dysfunction, Sopor
Patient was taking Depakene (View Usage). Patient experienced the following unwanted or unexpected effects: motor dysfunction, sopor on Jul 02, 2010 from FRANCE Additional patient health information: Female patient , 50 years of age, was diagnosed with self injurious behaviour, intentional overdose and. Depakene dosage: . During the same period patient was treated with DELORAZEPAM (View Delorazepam Review and Delorazepam Label ). Patient was hospitalized.

6827311-4 | Ataxia, Psychomotor Retardation
Adverse event was reported on Jun 30, 2010 by a Male patient taking Depakene (View Usage) (Dosage: ) was diagnosed with status epilepticus and. Location: FRANCE , 82 years of age, Patient had the following side effects: ataxia (What is ataxia?), psychomotor retardation. During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), ENAPREN (View Enapren Review and Enapren Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LANSOX (View Lansox Review and Lansox Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6820706-4 | Epilepsy
on Jun 29, 2010 Male patient from FRANCE , child 3 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Depakene (View Usage). After Depakene was administered, patient had the following side effects: epilepsy (What is epilepsy?). Depakene dosage: . Patient was hospitalized.

6813685-7 | Dermatitis Bullous, Scab
on Jun 21, 2010 Female patient from ITALY , 81 years of age, was diagnosed with affective disorder and was treated with Depakene (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis bullous, scab (What is scab?). Depakene dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), HUMALOG (View Humalog Review and Humalog Label ), SERENASE (View Serenase Review and Serenase Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), LANSOX (View Lansox Review and Lansox Label ), LASIX (View Lasix Review and Lasix Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

6812164-0 | Fall, Subcutaneous Haematoma
Patient was taking Depakene (View Usage). Patient had the following side effects: fall (What is fall?), subcutaneous haematoma on Jun 23, 2010 from FRANCE Additional patient health information: Female patient , 88 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), gastritis prophylaxis and. Depakene dosage: . During the same period patient was treated with WARFARIN SODIUM (Prn) (View Warfarin Sodium Review and Warfarin Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.